Max Georg Ostermeier

zfhn Zukunftsfonds Verwaltungs GmbH (ZFHN) is an independent German venture capital firm which was founded in 2005 to support the development of innovative start-up companies in Southern Germany. Headquartered in Heilbronn, ZFHN manages a venture capital fund backed by private investors. They also have a cooperative agreement with ZFH High-Tech Gründerfonds.

venture forum neckar eV provides matching services for investors and start-up companies. It offers technological, credential, and capital, financing, and credit services. The firm also provides funding advices. The company was founded by Stefan Reineck, Axel Krauss, and Tilmann Distelbarth in 2002 and is headquartered in Heilbronn, Germany.

3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors.

Peppermint VenturePartners GmbH (PVP) is an independent venture capital firm founded in 2008 by Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. It is headquartered in Berlin, Germany.

Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany.

Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany.

NVasc, Inc. is an early-stage ophthalmology company founded in February 2019 and funded by Kairos Ventures in November 2019. The company is based in Atherton, CA. The company is focused on treating the leading causes of blindness through choroidal and retinal revascularization. The company is planning to manufacture NVB001 that can be used in toxicokinetic studies and in early clinical trials in humans. NVasc has acquired the research rights to growth factors (NVB001 and NVB002) that have been shown to encourage the growth of non-leaking new vessels in the retina and choroid in mouse models of ischemic eye diseases.

Part of Carl-Zeiss-Stiftung, HYALTECH Ltd. develops and manufactures medical solutions. The company is based in Livingston, UK.

High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany.

Fci SAS provides ophthalmological surgery. The private company is based in Paris, France.

EnjoyVenture Management GmbH (EnjoyVenture) is an independent privately-owned venture capital firm established in 2000 and headquartered in Dusseldorf, Germany. EnjoyVenture invests their own capital. They have strategic alliances with the KfW banking group and with High-Tech Gründerfonds Management GmbH, a public-private partnership based in Bonn and specialized in early-stage technology investing. EnjoyVenture manages the ELS seed fund.

Aaren Scientific, Inc. manufactures intraocular lenses and surgical products. It offers hydrophilic IOLs with a refractive index equal aspheric optics to enhance contrast sensitivity in cases of lens misalignment, heparin surface modification for biocompatibility and preloaded lenses. The company was founded in 1989 and is headquartered in Ontario, CA.

KraussMaffei Technologies GmbH engages in the manufacture of plastic and rubber processing machinery and components. It operates through the following business divisions: Injection Molding Machinery, Reaction Process Machinery, and Automation. Its products include PETForm, MC6 Control System, Adaptive Process Control, WizardX, Sprue picker SPX 10, BluePower, industrial and linear robots, metering machines, mixing heads, piston and pump machines, and foam molds. The company was founded by Joseph Anton von Maffei in 1838 and is headquartered in Munich, Germany.

Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017.

KeepYourSight Foundation provides e-health initiative in the fight against blindness. The company is headquartered in united States.

The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD.

American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets.

The American Glaucoma Society supports glaucoma specialists and scientists through the advancement of education and research.

Women in Ophthalmology, Inc. provides support to ophthalmologists. It offers professional development, carrier advancement, and interactive networking to its members. The company is headquartered in Denver, CO.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Glaucoma Research Foundation provides education services. The non-profit company is based in San Francisco, CA. The company was founded by Adrienne L. Graves. The CEO is Thomas M. Brunner.

Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH.